Pharnext SCA Stock price

Equities

ALPHA

FR001400N1P4

Pharmaceuticals

Real-time Euronext Paris 10:22:21 2024-03-28 am EDT 5-day change 1st Jan Change
0.26 EUR -2.26% Intraday chart for Pharnext SCA -1.40% -87.00%
Sales 2021 3.56M 3.85M Sales 2022 2.26M 2.44M Capitalization 46.31K 50.04K
Net income 2021 -30M -32.42M Net income 2022 -38M -41.06M EV / Sales 2021 -
Net Debt 2021 14.24M 15.38M Net Debt 2022 22.16M 23.94M EV / Sales 2022 -
P/E ratio 2021 *
-
P/E ratio 2022
-
Employees 23
Yield 2021 *
-
Yield 2022
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.26%
1 week-1.40%
Current month-35.02%
1 month-40.91%
3 months-87.00%
6 months-100.00%
Current year-87.00%
More quotes
1 week
0.25
Extreme 0.25
0.30
1 month
0.23
Extreme 0.23
0.51
Current year
0.23
Extreme 0.23
3.00
1 year
0.23
Extreme 0.23
1 000 000.00
3 years
0.23
Extreme 0.23
1 000 000.00
5 years
0.23
Extreme 0.23
1 000 000.00
10 years
0.23
Extreme 0.23
1 000 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-11-07
Founder - 06-12-31
Chief Tech/Sci/R&D Officer - 20-11-30
Members of the board TitleAgeSince
Director/Board Member 58 22-06-15
Director/Board Member 77 20-07-16
Director/Board Member 64 23-07-09
More insiders
Date Price Change Volume
24-03-28 0.26 -2.26% 25 725
24-03-27 0.266 -6.63% 11,282
24-03-26 0.2849 +1.75% 14,590
24-03-25 0.28 +3.70% 10,650
24-03-22 0.27 +2.39% 16,341

Real-time Euronext Paris, March 28, 2024 at 10:22 am EDT

More quotes
Pharnext SCA specializes in the development of drugs based on PleotherapyTM for the treatment of severe, rare and common neurological diseases (including Alzheimer, Charcot-Marie Tooth disease, Parkinson's and amyotrophic lateral sclerosis). The company keeps creating new treatments by combining, at very low doses, molecules that are already tested for other diseases. The group has a portfolio of 2 products in clinical development: PXT3003 (treatment of the orphan disease Charcot-Marie-Tooth type 1A) and PXT864 (Alzheimer's disease treatment).
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Pharnext SCA - Euronext Paris